EMBC EMBECTA CORP

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results.

Visit the company’s Investor Relations website at to view the detailed first quarter fiscal 2026 and investor presentation.

The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessible , or access the teleconference .

A webcast replay of the call will be available beginning at 11:00 a.m. ET on February 5, 2026, via the embecta investor relations website and archived on the website for one year.

About embecta 

embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit  or follow our social channels on , , and .                                     

Contacts: 



 
Media

Christian Glazar

Sr. Director, Corporate Communications

908-821-6922



Investors 

Pravesh Khandelwal

VP, Head of Investor Relations

551-264-6547 





EN
05/02/2026

Underlying

EMBCEMBECTA CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EMBECTA CORP

 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta names new Chairman of the Board and Lead Independent Director

embecta names new Chairman of the Board and Lead Independent Director PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Board of Directors (the “Board”) of embecta has elected Devdatt “Dev” Kurdikar as Chairman of the Board and Dr. Claire Pomeroy as Lead Independent Director, effective immediately. These changes follow the previously announced retirement of LTG (Ret.) David F. Melcher, Non-Executiv...

February 11, 2026 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results. Visit the company’s Investor Relations website at to view the detailed first quarter fiscal 2026 and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February ...

February 5, 2026 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on March 17, 2026 to stockholders of record at the close of business on February 27, 2026. About embecta embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative soluti...

February 5, 2026 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Report Fiscal First Quarter Financial Results

embecta to Report Fiscal First Quarter Financial Results PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal first quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 5, 2026. Those who would like to participate may access the live webcast , or access the teleconference . ...

January 22, 2026 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT / 5:15 p.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at . About embectaembecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medica...

December 18, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch